Annual Total Long Term Liabilities
$176.79 M
+$21.77 M+14.04%
December 31, 2023
Summary
- As of February 7, 2025, HRTX annual total long term liabilities is $176.79 million, with the most recent change of +$21.77 million (+14.04%) on December 31, 2023.
- During the last 3 years, HRTX annual total long term liabilities has risen by +$162.23 million (+1114.16%).
- HRTX annual total long term liabilities is now at all-time high.
Performance
HRTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$175.24 M
-$521.00 K-0.30%
September 30, 2024
Summary
- As of February 7, 2025, HRTX quarterly total long term liabilities is $175.24 million, with the most recent change of -$521.00 thousand (-0.30%) on September 30, 2024.
- Over the past year, HRTX quarterly long term liabilities has dropped by -$521.00 thousand (-0.30%).
- HRTX quarterly long term liabilities is now -1.13% below its all-time high of $177.24 million, reached on September 30, 2023.
Performance
HRTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
HRTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.0% | -0.3% |
| 3 y3 years | +1114.2% | +8.7% |
| 5 y5 years | +100.0% | +1525.1% |
HRTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.0% | -1.1% | +13.9% |
| 5 y | 5-year | at high | +1344.2% | -1.1% | +1331.5% |
| alltime | all time | at high | -100.0% | -1.1% | -100.0% |
Heron Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $175.24 M(-0.3%) |
| Jun 2024 | - | $175.76 M(-0.3%) |
| Mar 2024 | - | $176.28 M(-0.3%) |
| Dec 2023 | $176.79 M(+14.0%) | $176.79 M(-0.3%) |
| Sep 2023 | - | $177.24 M(+15.3%) |
| Jun 2023 | - | $153.79 M(-0.4%) |
| Mar 2023 | - | $154.41 M(-0.4%) |
| Dec 2022 | $155.02 M(-1.3%) | $155.02 M(-0.4%) |
| Sep 2022 | - | $155.63 M(-0.4%) |
| Jun 2022 | - | $156.20 M(-0.4%) |
| Mar 2022 | - | $156.76 M(-0.2%) |
| Dec 2021 | $157.08 M(+978.8%) | $157.08 M(-2.6%) |
| Sep 2021 | - | $161.25 M(-0.5%) |
| Jun 2021 | - | $162.00 M(+1074.7%) |
| Mar 2021 | - | $13.79 M(-5.3%) |
| Dec 2020 | $14.56 M(+18.9%) | $14.56 M(-4.8%) |
| Sep 2020 | - | $15.30 M(-4.5%) |
| Jun 2020 | - | $16.01 M(-4.2%) |
| Mar 2020 | - | $16.71 M(+36.5%) |
| Dec 2019 | $12.24 M(>+9900.0%) | $12.24 M(+13.5%) |
| Sep 2019 | - | $10.78 M(-4.2%) |
| Jun 2019 | - | $11.25 M(-4.0%) |
| Mar 2019 | - | $11.72 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2017 | - | $25.00 M(0.0%) |
| Jun 2017 | - | $25.00 M(-50.0%) |
| Mar 2017 | - | $50.00 M(0.0%) |
| Dec 2016 | $50.00 M(>+9900.0%) | $50.00 M(0.0%) |
| Sep 2016 | - | $50.00 M(>+9900.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $64.00 K(+156.0%) |
| Jun 2011 | - | $25.00 K(-43.2%) |
| Mar 2011 | - | $44.00 K(+25.7%) |
| Dec 2010 | $35.00 K(-86.9%) | $35.00 K(-81.5%) |
| Sep 2010 | - | $189.00 K(-3.6%) |
| Jun 2010 | - | $196.00 K(-14.0%) |
| Mar 2010 | - | $228.00 K(-14.9%) |
| Dec 2009 | $268.00 K(-73.6%) | $268.00 K(+77.5%) |
| Sep 2009 | - | $151.00 K(-84.9%) |
| Jun 2009 | - | $1.00 M(0.0%) |
| Mar 2009 | - | $1.00 M(-1.5%) |
| Dec 2008 | $1.01 M | $1.01 M(-5.3%) |
| Sep 2008 | - | $1.07 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $1.13 M(-7.1%) |
| Mar 2008 | - | $1.22 M(-4.0%) |
| Dec 2007 | $1.27 M(+26.9%) | $1.27 M(+26.9%) |
| Sep 2007 | - | $1.00 M(0.0%) |
| Jun 2007 | - | $1.00 M(0.0%) |
| Mar 2007 | - | $1.00 M(0.0%) |
| Dec 2006 | $1.00 M(+189.9%) | $1.00 M(+1233.3%) |
| Sep 2003 | - | $75.00 K(-48.3%) |
| Jun 2003 | - | $145.00 K(0.0%) |
| Mar 2003 | - | $145.00 K(-58.0%) |
| Dec 2002 | $345.00 K(-56.1%) | $345.00 K(-54.7%) |
| Sep 2002 | - | $761.00 K(-8.9%) |
| Jun 2002 | - | $835.00 K(+6.3%) |
| Mar 2002 | - | $785.30 K(+0.0%) |
| Dec 2001 | $785.00 K(-10.2%) | $785.00 K(-7.6%) |
| Sep 2001 | - | $849.30 K(+16.0%) |
| Jun 2001 | - | $732.10 K(-14.6%) |
| Mar 2001 | - | $857.10 K(-1.9%) |
| Dec 2000 | $874.00 K(-74.9%) | $874.00 K(-6.6%) |
| Sep 2000 | - | $935.60 K(-65.9%) |
| Jun 2000 | - | $2.74 M(-55.9%) |
| Mar 2000 | - | $6.22 M(+78.3%) |
| Dec 1999 | $3.49 M(-41.9%) | $3.49 M(-58.5%) |
| Sep 1999 | - | $8.40 M(+115.4%) |
| Jun 1999 | - | $3.90 M(-7.1%) |
| Mar 1999 | - | $4.20 M(-30.0%) |
| Dec 1998 | $6.00 M(+22.4%) | $6.00 M(+300.0%) |
| Sep 1998 | - | $1.50 M(+1400.0%) |
| Jun 1998 | - | $100.00 K(-75.0%) |
| Mar 1998 | - | $400.00 K(-91.8%) |
| Dec 1997 | $4.90 M(-10.9%) | $4.90 M(+32.4%) |
| Sep 1997 | - | $3.70 M(-14.0%) |
| Jun 1997 | - | $4.30 M(-14.0%) |
| Mar 1997 | - | $5.00 M(-9.1%) |
| Dec 1996 | $5.50 M(-14.1%) | $5.50 M(-11.3%) |
| Sep 1996 | - | $6.20 M(+3.3%) |
| Jun 1996 | - | $6.00 M(-3.2%) |
| Mar 1996 | - | $6.20 M(-3.1%) |
| Dec 1995 | $6.40 M(+540.0%) | $6.40 M(+18.5%) |
| Sep 1995 | - | $5.40 M(+671.4%) |
| Jun 1995 | - | $700.00 K(-30.0%) |
| Mar 1995 | - | $1.00 M(0.0%) |
| Dec 1994 | $1.00 M(-70.6%) | $1.00 M(-67.7%) |
| Sep 1994 | - | $3.10 M(-3.1%) |
| Jun 1994 | - | $3.20 M(-3.0%) |
| Mar 1994 | - | $3.30 M(-2.9%) |
| Dec 1993 | $3.40 M(-8.1%) | $3.40 M(-2.9%) |
| Sep 1993 | - | $3.50 M(-2.8%) |
| Jun 1993 | - | $3.60 M(0.0%) |
| Mar 1993 | - | $3.60 M(-2.7%) |
| Dec 1992 | $3.70 M(-7.5%) | $3.70 M(-7.5%) |
| Sep 1992 | - | $4.00 M(0.0%) |
| Jun 1992 | - | $4.00 M(0.0%) |
| Mar 1992 | - | $4.00 M(0.0%) |
| Dec 1991 | $4.00 M(+33.3%) | $4.00 M(+33.3%) |
| Sep 1991 | - | $3.00 M(0.0%) |
| Jun 1991 | - | $3.00 M(+3.4%) |
| Mar 1991 | - | $2.90 M(-3.3%) |
| Dec 1990 | $3.00 M(0.0%) | $3.00 M(+2900.0%) |
| Jun 1990 | - | $100.00 K(-96.8%) |
| Mar 1990 | - | $3.10 M(+3.3%) |
| Dec 1989 | $3.00 M(+3.4%) | $3.00 M(0.0%) |
| Sep 1989 | - | $3.00 M(0.0%) |
| Jun 1989 | - | $3.00 M(+3.4%) |
| Dec 1988 | $2.90 M(-6.5%) | $2.90 M(-6.5%) |
| Dec 1987 | $3.10 M | $3.10 M |
FAQ
- What is Heron Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Heron Therapeutics?
- What is Heron Therapeutics annual total long term liabilities year-on-year change?
- What is Heron Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Heron Therapeutics?
- What is Heron Therapeutics quarterly long term liabilities year-on-year change?
What is Heron Therapeutics annual total long term liabilities?
The current annual total long term liabilities of HRTX is $176.79 M
What is the all time high annual total long term liabilities for Heron Therapeutics?
Heron Therapeutics all-time high annual total long term liabilities is $176.79 M
What is Heron Therapeutics annual total long term liabilities year-on-year change?
Over the past year, HRTX annual total long term liabilities has changed by +$21.77 M (+14.04%)
What is Heron Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of HRTX is $175.24 M
What is the all time high quarterly long term liabilities for Heron Therapeutics?
Heron Therapeutics all-time high quarterly total long term liabilities is $177.24 M
What is Heron Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, HRTX quarterly total long term liabilities has changed by -$521.00 K (-0.30%)